“In this ESCA study, the possibility of an immune response that selected for tumor cells lacking the DDX53 CTA is discussed.”
BUFFALO, NY- November 17, 2023 – A new research paper was published in Oncoscience (Volume 10) on November 10, 2023, entitled, “An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen.”
T-lymphocytes have been implicated in facilitating a pro-inflammatory, pro-tumorigenic microenvironment that worsens prognosis for esophageal carcinoma (ESCA). In their new study, researchers Peter Cheng, Konrad J. Cios, Mallika Varkhedi, Vayda R. Barker, Michelle Yeagley, Andrea Chobrutskiy, Boris I. Chobrutskiy, and George Blanck from the University of South Florida, Oregon Health and Science University Hospital and H. Lee Moffitt Cancer Center and Research Institute identified tumor resident, T-cell receptor (TCR) complementarity determining region-3 (CDR3) amino acid sequences and employed an algorithm particularly suited to the big data setting to evaluate TCR CDR3-cancer testis antigen (CTA) chemical complementarities.
“To better understand the potential positive and negative impacts of T-cells in ESCA, we recovered TCR recombination reads from the TCGA-ESCA whole exome sequence (WXS) files, obtained the TCR CDR3 AA sequences, and assessed the chemical complementarity of those sequences with CTAs, as those antigens have been characterized by many approaches over decades as candidate cancer antigens.”
Chemical complementarity of the ESCA TCR CDR3s and the cancer testis antigen DDX53 represented a disease-free survival (DFS) distinction, whereby the upper fiftieth percentile complementarity group correlated with worse DFS. The high TCR CDR3-DDX53 complementarity group also represented a greater proportion of tumor samples lacking DDX53 expression. These data and analyses raise the question of whether or not the TCR CDR3-DDX53 chemical complementarity assessment detected an ESCA immune response that selected for DDX53-negative cells.
“Overall, these data are consistent with the possibility that TCR-antigen interaction induces selective pressure that results in antigen loss, a process referred to as immuno-editing [16–18], and, eventually, tumor cell escape from an anti-tumor immune response. These data for ESCA are also consistent with similar data obtained for high CS, low survival in the ovarian cancer setting .”
Read the full study: DOI: https://doi.org/10.18632/oncoscience.590
Correspondence to: George Blanck
Keywords: adaptive immune receptor recombinations, complementarity determining region-3, esophageal cancer survival rates, cancer testis antigens
Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.
To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:
X, formerly known as Twitter
For media inquiries, please contact firstname.lastname@example.org.
Oncoscience Journal Office
6666 East Quaker Str., Suite 1D
Orchard Park, NY 14127
Phone: 1-800-922-0957, option 4
To reduce the side effects associated with chemotherapy treatments, researchers have investigated the use of delivery systems that can take more drugs directly to the tumor. Ninh (Irene) La-Beck, Pharm.D., from the Department of Immunotherapeutics and Biotechnology at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy is one of those researchers.
La-Beck recently received a five-year, $2.49 million grant (“Cholesterol Metabolism in the Pharmacology of Liposomal ...
Earth science researcher Dr. Antonia Gambacorta earned the 2023 Goddard IRAD Technology Leadership award for pioneering new ways to measure lower layers of Earth’s atmosphere from space.
The award from the chief technologist of NASA’s Goddard Space Flight Center in Greenbelt, Maryland, recognizes Gambacorta’s work demonstrating how hyperspectral microwave sounding, the measurement of hundreds of thousands of wavelengths of microwave light, could dissect Earth’s atmospheric planetary boundary layer (PBL). She also ...
BOSTON – Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment. Some studies have looked at replacing RGCs through cell transplants, but this process is still in the research and development stage and fraught with limitations that highlight a need for a more precise manner of effectively repopulating these cells in the retina. Now, a multidisciplinary team led by researchers at the Schepens Eye Research Institute of Mass Eye and Ear has ...
Rochester Institute of Technology’s Emiliano Brini, assistant professor in the School of Chemistry and Materials Science, has received an award from the National Institutes of Health (NIH) to support his research on building the next generation of drugs.
Brini and his team of students will develop computational tools that can predict the strength of the interaction between two proteins and how drugs will modify this interaction. Physics-based methodologies will quickly and accurately provide such predictions.
Designing a new ...
Small molecules called immunomodulators can help create more effective vaccines and stronger immunotherapies to treat cancer.
But finding the molecules that instigate the right immune response is difficult —the number of drug-like small molecules has been estimated to be 1060, much higher than the number of stars in the visible universe.
In a potential first for the field of vaccine design, machine learning guided the discovery of new immune pathway-enhancing molecules and found one particular small molecule that could outperform the best immunomodulators on the market. The ...
Seven scientists from the Department of Energy’s Oak Ridge National Laboratory have been named among the world’s most influential researchers on the 2023 Highly Cited Researchers list, produced by Clarivate, a data analytics firm that specializes in scientific and academic research.
"These scientists have delivered significant impact for the scientific community and nation," said ORNL Director Stephen Streiffer. "This honor highlights their commitment, hard work and leadership in their respective fields.”
The ORNL researchers named to the list are:
Miaofang Chi, Center for Nanophase Materials Sciences
David A. Cullen, Center for Nanophase Materials ...
A new understanding of lung cancer cells’ “memories” suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found.
Research from the lab of cancer biologist Tuomas Tammela, MD, PhD shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.
The study looked specifically at lung adenocarcinoma, a type of non-small ...
When Cyclone Idai swept through Mozambique’s Gorongosa National Park in May 2019, one of nature‘s deadliest forces encountered one of the most technologically sophisticated wildlife parks on the planet. Princeton researchers and colleagues from around the world documented the effects using trail cameras and animal-tracking devices that had been in use before the storm.
Thanks to the extensive network of cameras, GPS collars and other instruments, park staff and ...
DURHAM, N.C. – Nanoplastics interact with a particular protein that is naturally found in the brain, creating changes linked to Parkinson’s disease and some types of dementia.
In a Duke-led study appearing Nov. 17 in Science Advances, the researchers report that the findings create a foundation for a new area of investigation, fueled by the timely impact of environmental factors on human biology.
“Parkinson’s disease has been called the fastest growing neurological disorder in the world,” said principal investigator, Andrew West, Ph.D., professor in the Department of Pharmacology and Cancer Biology at ...
New research published today in leading international journal Science Advances paints an uncharacteristically upbeat picture for the planet. This is because more realistic ecological modelling suggests the world’s plants may be able to take up more atmospheric CO2 from human activities than previously predicted.
Despite this headline finding, the environmental scientists behind the research are quick to underline that this should in no way be taken to mean the world’s governments can take their foot off the brake in their obligations to reduce carbon ...